Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

501 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations.
Long L, Briscoe S, Cooper C, Hyde C, Crathorne L. Long L, et al. Among authors: hyde c. Health Technol Assess. 2015 Jan;19(8):1-134. doi: 10.3310/hta19080. Health Technol Assess. 2015. PMID: 25629427 Free PMC article. Review.
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Meads C, Cummins C, Jolly K, Stevens A, Burls A, Hyde C. Meads C, et al. Among authors: hyde c. Health Technol Assess. 2000;4(23):1-153. Health Technol Assess. 2000. PMID: 11074393 Review.
Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Brañas P, et al. Among authors: hyde c. Health Technol Assess. 2000;4(27):1-61. Health Technol Assess. 2000. PMID: 11074395 Review.
Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation.
Wake B, Hyde C, Bryan S, Barton P, Song F, Fry-Smith A, Davenport C. Wake B, et al. Among authors: hyde c. Health Technol Assess. 2002;6(3):1-85. doi: 10.3310/hta6030. Health Technol Assess. 2002. PMID: 12022936 Review. No abstract available.
Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
Hyde C, Wake B, Bryan S, Barton P, Fry-Smith A, Davenport C, Song F. Hyde C, et al. Health Technol Assess. 2002;6(2):1-89. doi: 10.3310/hta6020. Health Technol Assess. 2002. PMID: 12022937 Review. No abstract available.
Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders.
Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C. Adi Y, et al. Among authors: hyde c. Health Technol Assess. 2002;6(28):1-66. Health Technol Assess. 2002. PMID: 12583819 Review. No abstract available.
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.
Meads C, Salas C, Roberts T, Moore D, Fry-Smith A, Hyde C. Meads C, et al. Among authors: hyde c. Health Technol Assess. 2003;7(9):v-vi, 1-98. doi: 10.3310/hta7090. Health Technol Assess. 2003. PMID: 12709292 Review. No abstract available.
What is the cost of blindness?
Meads C, Hyde C. Meads C, et al. Among authors: hyde c. Br J Ophthalmol. 2003 Oct;87(10):1201-4. doi: 10.1136/bjo.87.10.1201. Br J Ophthalmol. 2003. PMID: 14507746 Free PMC article. Review. No abstract available.
Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.
Meads C, Hyde C. Meads C, et al. Among authors: hyde c. Br J Ophthalmol. 2004 Feb;88(2):212-7. doi: 10.1136/bjo.2003.019471. Br J Ophthalmol. 2004. PMID: 14736777 Free PMC article. Review.
Identification and assessment of ongoing trials in health technology assessment reviews.
Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, Hyde C. Song FJ, et al. Among authors: hyde c. Health Technol Assess. 2004 Nov;8(44):iii, 1-87. doi: 10.3310/hta8440. Health Technol Assess. 2004. PMID: 15525479 Review.
501 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback